Halozyme Therapeutics Inc
NASDAQ:HALO
Wall Street
Price Targets
HALO Price Targets Summary
Halozyme Therapeutics Inc
According to Wall Street analysts, the average 1-year price target for HALO is 52.13 USD with a low forecast of 39.39 USD and a high forecast of 75.6 USD.
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.
What is HALO's stock price target?
Price Target
52.13
USD
According to Wall Street analysts, the average 1-year price target for HALO is 52.13 USD with a low forecast of 39.39 USD and a high forecast of 75.6 USD.
What is Halozyme Therapeutics Inc's Revenue forecast?
Projected CAGR
17%
For the last 8 years the compound annual growth rate for Halozyme Therapeutics Inc's revenue is 25%. The projected CAGR for the next 3 years is 17%.
What is Halozyme Therapeutics Inc's Operating Income forecast?
Projected CAGR
33%
The compound annual growth rate of Halozyme Therapeutics Inc's operating income for the next 3 years is 33%.
What is Halozyme Therapeutics Inc's Net Income forecast?
Projected CAGR
41%
The compound annual growth rate of Halozyme Therapeutics Inc's net income for the next 3 years is 41%.